Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice by van der Schoot, L.S., Janssen, J.J., Bastiaens, M.T., de Boer-Brand, A., Christiaansen-Smit, C., Enomoto, D.N.H., Hovingh, R., Tupker, R.A., Seyger, M.M.B., Verhoef, L.M., van den Reek, J.M.P.A., de Jong, E.M.G.J.

Get full text

Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry by van der Schoot, L.S., van den Reek, J.M.P.A., Groenewoud, J.M.M., Otero, M.E., Njoo, M.D., Ossenkoppele, P.M., Mommers, J.M., Koetsier, M.I.A., Berends, M.A.M., Arnold, W.P., Peters, B., Andriessen, M.P.M., Den Hengst, C.W., Kuijpers, A.L.A., de Jong, E.M.G.J.

Get full text